Skip to main content

Table 1 Patients and treatment, and survival in unicentric retroperitoneal CD

From: Clinicopathological characteristics of unicentric retroperitoneal Castleman’s disease: a study of 14 cases

Patient (n)

Age (years)

Sex

Histological type

Treatment

Hospital stay (days)

Follow-up (months)

Outcome

1

39

F

HV

CR

15

80

A-NED

2

30

M

HV

CR

20

61

A-NED

3

31

F

HV

CR

18

59

A-NED

4

15

F

HV

CR

13

46

A-NED

5

44

M

HV

CR

26

40

A-NED

6

58

F

HV

CR

12

40

A-NED

7

32

F

HV

CR

21

33

A-NED

8

40

M

MIX

CR

15

30

A-NED

9

39

F

HV

CR

9

26

A-NED

10

24

M

HV

CR

38

22

A-NED

11

52

M

HV

CR

23

20

A-NED

12

51

F

HV

CR

11

3

A-NED

13

29

M

HV

CR

14

2

A-NED

14

42

F

HV

CR

16

17

A-NED

  1. A-NED alive and no evidence of disease, CR complete resection, F female, M male, HV hyaline vascular type, MIX mixed type